InsiderCEO
Neil Kumar Insider Trading Activity
Every SEC Form 4 transaction reported by Neil Kumar, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is Neil Kumar buying or selling?
Neil Kumar reported 3 open-market buys ($72.0M) and 50 sells ($145.1M) across 53 Form 4 filings at 2 companies — a net selling position of $73.1M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 8, 2026)
Total Form 4 filings
53
SEC EDGAR
Companies
2
Buys (3)
$72.0M
Sells (50)
$145.1M
Insider sentiment
Net sellingNet insider flow of $73.1M in net selling, filed between Jun 22, 2018 – Jun 8, 2026.
Companies Neil Kumar files for
Recent Neil Kumar transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Jun 8, 2026 | BBIO | Chief Executive Officer | Sale | 80.0K | $5.4M |
| May 26, 2026 | BBIO | Chief Executive Officer | Sale | 26.1K | $1.8M |
| May 11, 2026 | BBIO | Chief Executive Officer | Sale | 80.0K | $5.4M |
| Apr 13, 2026 | BBIO | Chief Executive Officer | Sale | 80.0K | $6.0M |
| Mar 16, 2026 | BBIO | Chief Executive Officer | Sale | 80.0K | $5.5M |
| Feb 23, 2026 | BBIO | Chief Executive Officer | Sale | 28.1K | $2.0M |
| Feb 12, 2026 | BBIO | Chief Executive Officer | Sale | 80.0K | $5.7M |
| Jan 13, 2026 | BBIO | Chief Executive Officer | Sale | 80.0K | $6.0M |
| Dec 16, 2025 | BBIO | Chief Executive Officer | Sale | 30.0K | $2.2M |
| Dec 8, 2025 | BBIO | Chief Executive Officer | Sale | 80.0K | $5.9M |
| Nov 24, 2025 | BBIO | Chief Executive Officer | Sale | 26.2K | $1.7M |
| Nov 10, 2025 | BBIO | Chief Executive Officer | Sale | 80.0K | $5.0M |
| Oct 10, 2025 | BBIO | Chief Executive Officer | Sale | 80.0K | $4.4M |
| Sep 8, 2025 | BBIO | Chief Executive Officer | Sale | 80.0K | $4.2M |
| Aug 22, 2025 | BBIO | Chief Executive Officer | Sale | 26.2K | $1.3M |
| Aug 11, 2025 | BBIO | Chief Executive Officer | Sale | 80.0K | $3.7M |
| Jul 3, 2025 | BBIO | Chief Executive Officer | Sale | 80.0K | $3.4M |
| May 20, 2025 | BBIO | Chief Executive Officer | Sale | 101.2K | $3.4M |
| Apr 24, 2025 | BBIO | Chief Executive Officer | Sale | 75.0K | $2.6M |
| Mar 27, 2025 | BBIO | Chief Executive Officer | Sale | 75.0K | $2.8M |
| Feb 27, 2025 | BBIO | Chief Executive Officer | Sale | 75.0K | $2.5M |
| Feb 20, 2025 | BBIO | Chief Executive Officer | Sale | 31.5K | $1.1M |
| Jan 30, 2025 | BBIO | Chief Executive Officer | Sale | 600.0K | $21.8M |
| Nov 21, 2024 | BBIO | Chief Executive Officer | Sale | 27.4K | $613.8K |
| Aug 20, 2024 | BBIO | Chief Executive Officer | Sale | 27.4K | $676.3K |
Showing the 25 most recent filings of 53. Screen every filing.
Neil Kumar insider trading FAQ
Is Neil Kumar buying or selling?
Across 53 SEC Form 4 filings, Neil Kumar reported 3 open-market purchases totaling $72.0M and 50 sales totaling $145.1M — a net selling position of $73.1M.
Which companies does Neil Kumar file Form 4s for?
Neil Kumar has reported insider transactions at 2 companies, most often BridgeBio Pharma, Inc. (BBIO), Eidos Therapeutics, Inc. (EIDX).
How far back does Neil Kumar's filing history go?
Trabud holds Neil Kumar's SEC Form 4 filings from Jun 22, 2018 – Jun 8, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Neil Kumar's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Neil Kumar and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener